20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Stable aqueous injectable solution of epinephrine
#8102Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#8103Automated production of viral vectors
#8104Inhibition of vascular matrix metalloproteinase-9 to treat ischemic injury
#8105HER3 binding agents and uses thereof
#8106MALARIA VACCINE
#8107Compounds for use as therapeutically active substances in the treatment of retinal diseases
#8108Compounds for use as therapeutically active substances in the treatment of retinal diseases
#8109BIOLOGICS LABELING SYSTEM AND METHODS THEREOF
#8110Methods of treating ulcerative colitis
#8111LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE
#8112Nucleotide sequence expressing an exosome-anchoring protein for use as vaccine
#8113TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#8114SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#8115Compositions comprising a bacterial strain of the genus and uses thereof
#8116COLLAGEN ENCAPSULATION OF INSULIN-PRODUCING CELLS
#8117HOMOGENEOUS POLYSACCHARIDE ESP-B4, DERIVED FROM HERBA EPHEDRA, PREPARATION METHOD AND MEDICAL USE THEREOF
#8118USE OF RIBOSE IN FIRST RESPONSE TO ACUTE MYOCARDIAL INFARCTION
#8119Physiologically balanced injectable formulations of fosnetupitant
#8120Quinazolines compound, preparation method therefor and application thereof
#8121TYROSINE KINASE INHIBITOR FORMULATIONS FOR THE TREATMENT OF MAST CELL-MEDIATED INFLAMMATORY DISEASES AND METHODS OF USE THEREOF
#8122Methods of treating respiratory disorders
#8123SYSTEMS, METHODS, AND FORMULATIONS FOR TREATING CANCER
#8124Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
#8125METHODS AND COMPOSITIONS FOR TREATMENT OF PAIN USING CAPSAICIN
#8126Epinephrine formulations
#81277-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy
#8128INSTANT THICKENED DRY FOOD COMPOSITIONS
#8129POLYETHYLENIMINE NANOPARTICLES AND METHODS OF USING SAME
#8130Formulations for intravenous administration
#8131AUTOLOGOUS STEM CELL THERAPIES FOR TREATMENT OF EYE DISEASE
#8132siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#8133Compounds and methods for reducing Tau expression
#8134Methods for treating patients with hyperlipidemia by administering a PCSK9 inhibitor in combination with an ANGPTL3 inhibitor
#8135Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
#8136Calcitonin Mimetics for Treating Diseases and Disorders
#8137Method treating malignant ascites and metastatic pleural effusion with and disulfide-linked trimeric TRAIL
#8138T-cell modulatory multimeric polypeptides and methods of use thereof
#8139Cationic lipids for therapeutic agent delivery formulations
#8140Apparatus for a mass production of monodisperse biodegradeable polymer-based microspheres and a multi-channel forming device incorporatable therein
#8141Fat droplets in retina and optic nerve as a diagnostic marker for neurodegeneration and glaucoma in humans
#8142COMBINATION CANCER THERAPY USING CHIMERIC ANTIGEN RECEPTOR ENGINEERED NATURAL KILLER CELLS AS CHEMOTHERAPEUTIC DRUG CARRIERS
#8143Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
#8144Modulators of PCSK9 expression
#8145Pharmaceutical formulation
#8146Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
#8147MIC-1 and GLP-1 for use in the treatment of obesity
#8148Oncolytic virus for expression of immune checkpoint modulators
#8149STEM CELL DELIVERED ONCOLYTIC HERPES SIMPLEX VIRUS AND METHODS FOR TREATING BRAIN TUMORS
#8150Methods of treating neuropsychiatric disorders
#8151COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS CONTAINING EXOSOMES ISOLATED FROM STEM CELLS AS ACTIVE INGREDIENT
#8152Compositions for cancer therapy and methods
#8153Preparation of B4 for injection
#8154Targeting kinases for the treatment of cancer metastasis
#8155Emulsion formulations of aprepitant
#8156Combination therapy
#8157Treatment of breast cancer using combination therapies comprising an AKT inhibitor, a taxane, and a PD-L1 inhibitor
#8158TREATMENT OF RESTENOSIS USING TEMSIROLIMUS
#8159TREATMENT WITH NMDA RECEPTOR MODULATORS
#8160CATIONIC LIQUID CRYSTALLINE NANOPARTICLES
#8161Venus Protocol Method for Enhancing Female Sexual Wellness with Shockwave Therapy and Stem Cells
#8162Method for treating cancer using disulfide-linked trimeric 4-1BBL
#8163IP-10 antibodies and their uses
#8164Immunotherapy for Clearing Pathological Tau Conformers
#8165Fatty acid modified human epidermal growth factor
#8166CONSTITUTIVELY ACTIVE PROFILIN-1 FOR USE IN THE THERAPY AND/OR TREATMENT OF A NEUROLOGICAL DISORDER AND/OR FOR PROMOTING NEURONAL REGENERATION, KIT AND PRODUCTS THEREOF
#8167Activators of the unfolded protein response
#8168PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
#8169Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#8170Hepatitis C virus gene sequences and methods of use therefor
#8171Vaccine comprising toxoids
#8172High concentration alpha-glucosidase compositions for the treatment of Pompe disease
#8173Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
#8174Stromal derived factor 1 and its use in the prevention and treatment of erectile dysfunction
#8175PRE-MIXED, READY TO USE VANCOMYCIN COMPOSITIONS
#8176PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS
#8177Methods for the prevention or treatment of heart failure
#8178Treatment of multiple sclerosis with adipose-derived stem cells
#8179Prophylactic or therapeutic agent for inflammatory bowel disease
#8180In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid
#8181Formulations of deoxycholic acid and salts thereof
#8182Methods of reducing risk of preterm birth
#8183FULVESTRANT FORMULATIONS
#8184LIQUID FORMULATIONS OF FOSAPREPITANT
#8185Composition and methods for preventing or reducing the incidence of transient ischemic attacks
#8186Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer
#8187Methods for solid tumor treatment
#8188Methods for solid tumor treatment
#8189Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses
#8190Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer
#8191Sustained release suspension containing dezocine analogue ester and preparation method therefor
#8192Methods for the treatment of tinnitus induced by cochlear excitotoxicity
#8193Nanoparticles Containing a Taxane and Their Use
#8194NOVEL ADMINISTRATION ROUTES FOR IMMUNE AGONISTS
#8195GENE THERAPY SYSTEMS AND RELATED METHODS FOR TREATMENT OF HEARING LOSS
#8196and enrichment strategy targeting lymphocytes derived from vector transduced HSCs for therapy of disorders
#8197METHODS OF ADMINISTERING ANTI-TNFALPHA ANTIBODIES
#8198Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them
#8199FORMULATIONS OF ANTIBODY MOLECULES TO INFLUENZA VIRUS
#8200Targeting α2δ-1-bound glutamate receptors for treating diseases and disorders
#8201Compstatin analogs with increased solubility and improved pharmacokinetic properties
#8202Fused ring compounds
#8203COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
#8204SYSTEMS AND METHODS FOR BOTULINUM TOXIN OR OTHER DRUG INJECTIONS FOR MEDICAL TREATMENT
#8205Drug delivery device
#8206Contrast Agents and Methods of Making the Same for Spectral CT That Exhibit Cloaking and Auto-Segmentation
#8207TARGETED DELIVERY OF THERAPEUTIC AGENTS AND IMAGING REAGENTS TO PANCREATIC CANCER CELLS
#8208Biodegradable block copolymer drug delivery composition
#8209INJECTABLE PREPARATION
#8210METHODS OF TREATMENT FOR CERVICAL DYSTONIA
#8211Methods and compositions for CNS delivery of arylsulfatase A
#8212INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHICH PI IS FROM 5.8 TO 8.5 AND A CO-POLYAMINO-ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS AND A LIMITED AMOUNT OF M-CRESOL
#8213METHOD OF TREATING PEDIATRIC DISORDERS
#8214Methods for regulating free fatty acid flux using fat specific protein 27 (FSP27) compositions
#8215Intrathecal delivery of recombinant adeno-associated virus encoding Methyl-CpG binding protein 2
#8216AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES
#8217IP and IP analogs dosage regimens for the treatment of ectopic calcifications
#8218Ganaxolone for use in prophylaxis and treatment of postpartum depression
#8219MONOHYDROXYLATED 17ALPHA-HYDROXYPROGESTERONE CAPROATE FOR REDUCING CONTRACTILITY
#8220Idelalisib for Treating Proliferative Vitreoretinopathy and Abnormal Intraocular Neovascularization
#8221Vasodilators for treatment of heart failure
#8222Compositions, devices, and methods for treating or preventing headaches
#8223Formulations of oxabicycloheptanes and oxabicycloheptenes
#8224Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, Rett syndrome, and Fragile X syndrome
#8225PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
#8226Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
#8227Stabilizing Camptothecin Pharmaceutical Compositions
#8228Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer
#8229TREATMENT OF DEPRESSIVE DISORDERS
#8230Methods and compositions for treatment of epileptic disorders
#8231METHODS AND COMPOSITIONS FOR TREATING MULTIPLE MYELOMA AND INCREASING ANTIBODY DEPENDENT CELL CYTOTOXICITY BY TARGETING THE ARYL HYDROCARBON RECEPTOR
#8232Tiglien-3-one derivatives
#8233COMPOSITION AND METHOD FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND CEREBRAL INJURY
#8234Epinephrine compositions and containers
#8235Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer
#8236Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
#8237Micelle constructs comprising curcumin
#8238COMPOSITIONS AND METHODS FOR TREATING ACUTE CANNABINOID OVERDOSE WITH A CANNABINOID RECEPTOR ANTAGONIST
#8239FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF
#8240DRY INTRAVENOUS POWDER COMPOSITIONS AND USES THEREOF
#8241REPROGRAMMING METABOLISM BY INHIBITING VHL FOR TREATMENT OF NEURODEGENERATION
#8242INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-TRNA SYNTHETASES
#8243Methods for treatment or prevention of a neurological immunity disorder
#8244HYDROCHLORIDE SALTS OF C5A RECEPTOR AGONIST PEPTIDES
#8245Dihydropyrimidinyl benzazepine carboxamide compounds
#8246DENDRIMER-BIOADHESIVE POLYMER HYDROGEL NANOGLUE AND USE THEREOF
#8247Dosage regimes for the administration of an anti-CD19 ADC
#8248Pharmaceutical composition
#8249COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER POSITIVE FOR EGFR MUTATION
#8250TREATMENT WITH ANTI-VEGF ANTIBODIES
#8251COMPOSITIONS AND METHODS FOR IMPROVING COGNITION
#8252METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF DIABETES
#8253Reconstituted high density lipoprotein formulation and production method thereof
#8254TREATMENT OF LIVER FAILURE WITH ACTIVATED T REGULATORY CELLS
#8255Topical composition for the treatment of mucosal lesions
#8256Modulation of the notch signaling pathway for treatment of respiratory disorders
#8257Methods for treating hepatitis B infection
#8258Neuroactive steroids, compositions, and uses thereof
#8259PREVENTION OF BOAR TAINT AND AGGRESSION
#8260Dosing regimen for sedation with CNS 7056 (remimazolam)
#8261Neuroquiescence—a treatment for neurological and nervous system bioelectrical dysregulation associated with seizures of epilepsy
#8262DEPOT ADMINISTRATION OF ILOPERIDONE
#8263Compositions and methods for reducing muscle contraction
#8264Pharmaceutical composition for treating migraine
#8265TREATMENT OF HYPERPLASTIC TISSUE GROWTHS INCLUDING BENIGN PROSTATIC HYPERPLASIA (BPH) BY DIRECT INJECTION OF AN ANTINEOPLASTIC AGENT
#8266Treatment of diabetes mellitus by long-acting formulations of insulins
#8267METHOD OF TREATING OSTEOARTHRITIS
#8268Compositions for the treatment of disease
#8269Methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
#8270Compositions and methods for the treatment of complications and disorders relating to Von Willebrand Factor
#8271Therapeutic splice-switching oligonucleotides
#8272Methods of CD40 activation and immune checkpoint blockade
#8273IMMUNOCONJUGATES WITH OPTIMIZED LINKERS AND ORIENTATION
#8274Compositions comprising D-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies
#8275Compositions and methods of use for treating metabolic disorders
#8276Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#8277Methods and compositions for inhibiting the interaction of menin with MLL proteins
#8278SURGICAL METHODS EMPLOYING PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS
#8279Pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine
#8280ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBINATION THERAPIES
#8281APPLICABLE CHEMICAL COMPOSITION COMPRISING AN AGENT CONJUGATED TO A HYDROPHOBIC MOIETY AND A CARRIER
#8282Pharmaceutical composition containing botulinum neurotoxin
#8283TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#8284GLP-1 compositions and uses thereof
#8285TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#8286TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#8287MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS
#8288Use of interleukin-4-inducing principle of eggs for treating pain, interstitial cystitis and/or overactive bladder
#8289Methods for preventing and treating pneumocystis infections
#8290NANOVESICLES PRODUCED FROM MESENCHYMAL STROMAL CELLS FOR ANTI-INFLAMMATORY APPLICATIONS
#8291Use of cladribine for treating autoimmune neuromuscular disease
#8292Storage-stable ready-to-use injectable formulations of thiotepa
#8293TRIMEGESTONE (TMG) FOR TREATMENT OF PRETERM BIRTH
#8294Hazardous agent injection system
#8295USE OF GABAA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXCESSIVE SLEEPINESS AND DISORDERS ASSOCIATED WITH EXCESSIVE SLEEPINESS
#8296Use of inhibitors of Bruton's tyrosine kinase (Btk)
#8297INJECTABLE FORMULATION
#8298DIRECT BRAIN ADMINISTRATION OF CHEMOTHERAPEUTICS TO THE CSF FOR PATIENTS WITH PRIMARY AND SECONDARY BRAIN TUMORS
#8299METHODS OF TREATMENT USING NIMODIPINE PARENTERAL FORMULATIONS
#8300Oxo-M and 4-PPBP induction of tenogenic differentiation of perivascular tendon stem cells
#8301Pharmaceutical compositions comprising nitroxyl donors
#8302Taxane particles and their use
#8303Maresins for use in the treatment of CNS injuries
#8304Probenecid for use in treating epileptic diseases, disorders or conditions
#8305Method of increasing melatonin synthesis to treat insomnia, ameliorate sleep disturbance and regulate sleep
#8306Pharmaceutical composition for reducing local fat and uses thereof
#8307Biodegradable block copolymer drug delivery composition
#8308Biological self-assembled nanocrystal injection having a lymphatic targeting function and preparation method
#8309METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#8310Compositions and methods for adoptive cell therapy for cancer
#8311Compositions and methods for treating retinal diseases
#8312METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#8313Biopharmaceutical compositions and methods for pediatric patients
#8314Methods and compositions for delivering MRNA coded antibodies
#8315SYNTHETIC HEME-CONTAINING MOLECULES AND THEIR USE
#8316Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer
#8317Ultra-long acting insulin-Fc fusion proteins and methods of use
#8318Ultra-long acting insulin-Fc fusion proteins and methods of use
#8319Ultra-long acting insulin-FC fusion proteins and methods of use
#8320Modulation of Wnt5a to Treat Glaucoma
#8321Reinforced macrocyclic ligands, complexes thereof, and uses of same
#8322Isolatable automatic drug compounding system
#8323Lanthanide complex formulations
#8324Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid
#8325Delivery of nanoparticles
#8326LIQUID PHARMACEUTICAL COMPOSITION
#8327COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER
#8328COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY
#8329Use of pertussis toxin as a therapeutic agent
#8330USE OF MANGANESE SUPEROXIDE DISMUTASE WITH HIGH STABILITY
#8331Compositions and methods for treating obesity and hyperphagia
#8332PROMOTING LUNG GROWTH
#8333Therapeutic compositions and methods of use for treating cancer
#8334Mesenchymal stem cells with enhanced immunosuppressive capability
#8335Therapeutic Treatments Via Intravenous Infusion Of Mesenchymal Stem Cells
#8336Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
#8337Use of oligonucleotides for the treatment and prevention of pain
#8338Pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine
#8339Drug formulations
#8340Process for Hydrating Cyclophosphamide Freeze-Dried Composition and Product Thereof
#8341Pharmaceutical formulations for subcutaneous administration
#834219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
#8343Nanoparticulate Meloxicam Formulations
#8344Method of treating pulmonary arterial hypertension
#8345Short-Acting Dihydropyridines (Clevidipine) For Use in Reducing Stroke Damage
#83461H-PYRAZOLO[3,4-B]PYRIDINES AND THERAPEUTIC USES THEREOF
#8347Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
#8348Compositions and methods of treating cardiac fibrosis with ifetroban
#8349INTRAMUSCULAR ATOVAQUONE FOR MALARIA PROPHYLAXIS
#8350Use of IL-22 dimer in manufacture of a medicament for intravenous administration
#8351Devices and systems for ablation therapy
#8352RECOMBINANT HERPES SIMPLEX VIRUS, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#8353Methods of isolation and use of CD39 stromal stem cells
#8354Methods of T cell expansion and activation
#8355NK cell-activating fusion protein, NK cell, and pharmaceutical composition including same
#8356Methods and compositions for treating perennial allergic conjunctivitis and keratoconjunctivitis
#8357Methods of Treating Inflammatory Pain
#8358Therapeutic variant alpha-2-macroglobulin compositions
#8359C4BP-based compounds for treating immunological diseases
#8360Norovirus fusion proteins and VLPS comprising norovirus fusion proteins
#8361TREATMENT OF COMPLEMENT-MEDIATED DISORDERS
#8362NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF
#8363Application of combination of polyethylene glycol and local anesthetic in non-narcotic analgesia
#8364THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA
#8365METHOD OF TREATING HEEL PAIN
#8366AAV9-mediated gene therapy for treating mucopolysaccharidosis type I
#8367TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#8368TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#8369Therapeutic RNA
#8370Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases
#8371Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
#8372Methods of treating basal cell carcinoma and glioblastoma
#8373S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS
#8374COMBINATION CANCER THERAPY
#8375Use of icaritin in preparing medicament for preventing or treating hematocytopenia
#8376Regimens for treating HIV infections and AIDS
#8377Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
#8378Use of sirolimus to treat exudative age-related macular degeneration with persistent edema
#83792-iminobiotin for use in the treatment of brain cell injury
#8380NEW TREATMENT OF BRAIN CANCER
#8381Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
#8382Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
#8383Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
#8384Method of treating post-traumatic stress disorder
#8385Levodopa infusion solution
#8386Composition for injection
#8387Methods and compositions for treating a proprotein convertase subtilisin kexin (PCSK9) gene-associated disorder
#8388Compositions for treating retinal diseases and methods for making and using them
#8389Anti-IL1RAP antibodies and antibody drug conjugates
#8390METHOD FOR THE TREATMENT OF IMMUNE THROMBOCYTOPENIA
#8391METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS
#8392ApoC-II mimetic peptides
#8393Whitening composition containing novel quercetin-based compound
#8394ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS
#8395DIHYDRATE OF BENZOTHIOPHENE COMPOUND OR OF A SALT THEREOF, AND PROCESS FOR PRODUCING THE SAME
#8396Tubing set with antimicrobial properties
#8397Portable drug mixing and delivery device and associated methods
#8398NUCLEIC ACID-CATIONIC POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#8399AAV VECTOR FOR TREATMENT OF FRIEDREICH'S ATAXIA
#8400ST-246 liquid formulations and methods